Skip to main content
NUTRITION 2023 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Topical Area: Aging and Chronic Disease

Aging and Chronic Disease (Poster Session)

(P23-003-23) Preventive Effects of Red Ginseng on an Aging Hallmark - Senescence

Monday, July 24, 2023
11:45 AM – 12:45 PM ET
Location: Poster Board 3

    Presenting Author(s)

  • Juliana Arndt

    Undergraduate Researcher
    Oklahoma State University
    Stillwater, Oklahoma, United States

    • Co-Author(s)

  • Da-Yeon Lee, MS

    Graduate Research Assistant
    Oklahoma State University
    Stillwater, Oklahoma, United States

  • Yoo Kim, Dr, PhD

    Assistant Professor
    Oklahoma State University
    Stillwater, Oklahoma, United States

Disclosure(s):
Juliana Arndt: No relevant financial relationship(s) with ineligible companies to disclose.
Da-Yeon Lee, MS: No relevant financial relationship(s) with ineligible companies to disclose.


Objectives: By 2030, 1 in 6 people in the world will be aged 60 years or older, increasing the importance of interventional therapies for age-associated diseases. Research investigating cultural dietary differences recognized that the use of herbal medicine supplementation such as processed Panax ginseng, referred to as red ginseng (RG), increases lifespan in Asian countries by facilitating healthy aging. However, the mechanism for how RG prevents, delays, or reverses aging-related diseases is unknown. Thus, this study assessed how RG facilitates healthy aging by identifying cellular and molecular mechanisms of hepatic senescence pathways in an aged mouse model.

Methods: This study compared three groups of wild-type (C57BL/6) mice: control young mice (3-month-old), control old mice (18-month-old equivalent to 60-year-old human beings), and RG-treated old mice (18-month-old). The RG-treated mice received 300 mg/kg body weight/day of RG via oral gavage injection for 4 weeks. To evaluate how RG delays hepatic cellular senescence, we analyzed the protein expression levels of the main senescence effectors (p53, p21, and p27) from liver tissue samples and primary hepatocytes. 

Results: The aged mice treated with RG did not show differences in body weight, ad libitum and fasting blood glucose levels, and food intake compared to control old mice. RG-treated old mice showed significantly reduced protein expression levels of cellular senescence markers, p53 and p21 in primary hepatocytes and p27 and p21 in liver samples compared to the control aged mice. These protein expression levels are closer to the expression observed from the control young mice.

Conclusions: RG supplementation attenuates hepatic cellular senescence by downregulating p53/p21 and p27 pathways. Therefore, our results suggest that RG could be a novel interventional agent for delaying cellular senescence. 

Funding Sources: Start-up funding from the Vice President of Research's Office at Oklahoma State University.